EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives

Sandeep Bindra, Won Kyeong Jeong, Muzammil Kabier, Sunil Kumar, Sachithra Thazhathuveedu Sudevan, Harish Chandra Vishwakarma, Della Grace Thomas Parambi, Naseer Maliyakkal, Sandeep Kumar, Leena K Pappachen, Hoon Kim, Bijo Mathew

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Sandeep Bindra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, India. Hauptthemen laut MEDLINE: Thiosemicarbazones, Monoamine Oxidase Inhibitors, Semicarbazones, Monoamine Oxidase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deanship of Research and Graduate Studies at King Khalid University, National Research Foundation of Korea (NRF), Korean Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty semicarbazone and thiosemicarbazone derivatives ( T1–T20 ) were synthesized and evaluated for their inhibition of monoamine oxidases and cholinesterases. Most compounds showed stronger inhibition of MAO‐B than MAO‐A. Among the synthesized compounds, T6 most strongly inhibited MAO‐B (IC 50 = 6.45 µM), followed by T17 (IC 50 = 9.46 µM). T6 and T17 exhibited the highest selectivity index values (3.60 and >4.23, respectively) for MAO‐B as compared with MAO‐A. T6 was a competitive MAO‐B inhibitor. Regarding structure–activity relationship, the thiosemicarbazone T1 (IC 50 = 20.74 µM) showed >1.93 times better MAO‐B inhibition than the semicarbazone T5 (IC 50 >40 µM); a similar pattern was observed for T6 vs. T10 , T11 vs. T15 , and T16 vs. T20 , indicating that the thiosemicarbazone derivatives exhibited better MAO‐B inhibition than the semicarbazone derivatives when the terminal –NH 2 group was free. All the compounds showed less than 50% inhibition of acetylcholinesterase at 10 µM. Comparatively, compounds T3 and T12 exhibited 70.65 and 61.94% inhibition of butyrylcholinesterase at 10 µM, respectively. Docking studies of the MAO‐B inhibition of the most promising molecules were performed using MzDOCK. Collectively, thiosemicarbazone derivatives, specially T6 and T17 , warrant further investigation as the promising candidates for the development of novel therapeutics targeting MAO‐B‐related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesMonoamine Oxidase InhibitorsSemicarbazonesMonoamine OxidaseCholinesterase InhibitorsStructure-Activity RelationshipButyrylcholinesteraseHumansAcetylcholinesteraseMolecular Docking SimulationMolecular StructureAnimalsDose-Response Relationship, Drug

Stichwörter der Autor:innen

MzDOCKbutyrylcholinesterasemonoamine oxidase‐Bsemicarbazonesstructure–activity relationshipsthiosemicarbazones

Substanzen

ThiosemicarbazonesMonoamine Oxidase InhibitorsSemicarbazonesMonoamine OxidaseCholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesterase

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, India.
  • Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, South Korea.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Department of Basic Medical Sciences, College of Applied Medical Sciences, King Khalid University, Khamis Mushait, Saudi Arabia.
  • School of Pharmacy & DST-FIST, Sharda University, Greater Noida, Uttar Pradesh, India.

Förderung

  • Deanship of Research and Graduate Studies at King Khalid University
  • National Research Foundation of Korea (NRF)
  • Korean Government

Zitieren

APA

Bindra, S., Jeong, W. K., Kabier, M., Kumar, S., Sudevan, S. T., Vishwakarma, H. C., Parambi, D. G. T., Maliyakkal, N., Kumar, S., Pappachen, L. K., Kim, H., & Mathew, B. (2026). Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71405

Vancouver

Bindra S, Jeong WK, Kabier M, Kumar S, Sudevan ST, Vishwakarma HC, et al. Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71405

BibTeX
@article{Bindra2026,
  author = {Bindra, Sandeep and Jeong, Won Kyeong and Kabier, Muzammil and Kumar, Sunil and Sudevan, Sachithra Thazhathuveedu and Vishwakarma, Harish Chandra and Parambi, Della Grace Thomas and Maliyakkal, Naseer and Kumar, Sandeep and Pappachen, Leena K and Kim, Hoon and Mathew, Bijo},
  title = {Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71405}
}
Kostenlos starten →